We are live on ! Find out more
D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $166B
1-Year Est. Return 43.98%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Fund
S&P 500
This Quarter Est. Return
-0.75%
1 Year Est. Return
+43.98%
3 Year Est. Return
+138.44%
5 Year Est. Return
+164.23%
10 Year Est. Return
+713.02%
AUM
$111B
AUM Growth
-$5.05B
Cap. Flow
-$8.92B
Cap. Flow %
-8.05%
Top 10 Hldgs %
9.24%
Holding
5,618
New
915
Increased
1,819
Reduced
1,634
Closed
695

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.07B
2
AMZN icon
Amazon
AMZN
+$486M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$443M
4
CRM icon
Salesforce
CRM
+$363M
5
QCOM icon
Qualcomm
QCOM
+$352M

Sector Composition

Rank Sector Weight
1 Technology 14.27%
2 Consumer Discretionary 9.91%
3 Healthcare 7.11%
4 Financials 6.94%
5 Communication Services 6.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNT
3951
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$484K ﹤0.01%
62,882
-3,400
-5% -$31K
BDSI
3952
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$484K ﹤0.01%
134,048
-52,507
-28% -$198K
BRY
3953
DELISTED
Berry Corp
BRY
$483K ﹤0.01%
67,004
-54,812
-45% -$324K
AIN icon
3954
Albany International
AIN
$2.18B
$482K ﹤0.01%
6,273
+50
+0.8% +$4.02K
BAP icon
3955
Credicorp
BAP
$31.2B
$482K ﹤0.01%
4,345
-7,862
-64% -$857K
ILPT
3956
Industrial Logistics Properties Trust
ILPT
$605M
$482K ﹤0.01%
+18,978
New +$507K
FRBK
3957
DELISTED
Republic First Bancorp Inc
FRBK
$482K ﹤0.01%
156,401
-25,030
-14% -$87K
KSI
3958
DELISTED
Kadem Sustainable Impact Corporation Class A common stock
KSI
$482K ﹤0.01%
+49,484
New +$477K
ABTX
3959
DELISTED
Allegiance Bancshares
ABTX
$479K ﹤0.01%
12,546
+6,731
+116% +$247K
CMCO icon
3960
Columbus McKinnon
CMCO
$478M
$478K ﹤0.01%
9,884
-6,490
-40% -$294K
BSAQ
3961
DELISTED
Black Spade Acquisition Co
BSAQ
$478K ﹤0.01%
+49,412
New +$480K
LQDA icon
3962
Liquidia Corp
LQDA
$7.57B
$476K ﹤0.01%
172,419
+26,787
+18% +$69.6K
HYLN icon
3963
Hyliion Holdings
HYLN
$635M
$475K ﹤0.01%
+56,510
New +$521K
KFRC icon
3964
Kforce
KFRC
$1.05B
$473K ﹤0.01%
7,934
+2,928
+58% +$177K
KOP icon
3965
Koppers
KOP
$968M
$473K ﹤0.01%
15,138
-5,966
-28% -$186K
OPAD icon
3966
Offerpad Solutions
OPAD
$19.1M
$473K ﹤0.01%
362
-2,985
-89% -$4.59M
CSTL icon
3967
Castle Biosciences
CSTL
$745M
$472K ﹤0.01%
+7,104
New +$500K
LCTX icon
3968
Lineage Cell Therapeutics
LCTX
$269M
$472K ﹤0.01%
187,486
+162,267
+643% +$416K
MRSN
3969
PUT
DELISTED
Mersana Therapeutics
MRSN
$472K ﹤0.01%
+2,000
New +$584K
CTOS.WS
3970
DELISTED
Custom Truck One Source, Inc. Warrants, exerciseable for Common Stock
CTOS.WS
$472K ﹤0.01%
216,666
PRDS
3971
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$470K ﹤0.01%
47,200
FSRD
3972
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$470K ﹤0.01%
+47,596
New +$468K
HEPS
3973
D-Market Electronic Services & Trading
HEPS
$1.05B
$469K ﹤0.01%
+68,343
New +$745K
BE icon
3974
CALL
Bloom Energy
BE
$46.3B
$468K ﹤0.01%
+25,000
New +$529K
IDXX icon
3975
Idexx Laboratories
IDXX
$44.9B
$468K ﹤0.01%
752
+300
+66% +$202K

Similar funds

D.E. Shaw & Co's Q3 2021 Portfolio in Review

As of Q3 2021, D.E. Shaw & Co held 5,618 positions worth $111B, down 4.4% from $116B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.

D.E. Shaw & Co withdrew a net $8.92B in Q3 2021, closing 695 positions and reducing 1,634 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $228M position sold in full.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, D.E. Shaw & Co opened a new position in Sea Limited worth $206M.

  • D.E. Shaw & Co's largest Q3 2021 buy was Sea Limited: 645,697 shares worth $206M.
  • D.E. Shaw & Co added most to Activision Blizzard in Q3 2021, an estimated $757M increase.
  • D.E. Shaw & Co's biggest Q3 2021 reduction was Apple, cutting an estimated $1.07B.
  • D.E. Shaw & Co fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $228M.
  • D.E. Shaw & Co's ten largest holdings make up 9.2% of its $111B portfolio in Q3 2021.
  • D.E. Shaw & Co opened 915 new positions and closed 695 in Q3 2021.
  • D.E. Shaw & Co's portfolio value fell 4.4% quarter-over-quarter to $111B.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.